Institutional Ownership Agios Pharmaceuticals, Inc. (AGIO)
This table provides information about the institutional ownership of Agios Pharmaceuticals, Inc. (AGIO). We have compiled data on the 256 institutions that hold shares in the stock, with a total of 63.8 Million shares, which have been reported (via 13F filing form) to have a value of $2.78 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Nov 14, 2025 Q3 2025 |
679,922
shares
|
$29.7 Million
0.58% of portfolio
|
Q3 2025
Added 3.22%
|
|
|
Scs Capital Management LLC
Boston, MA |
Nov 13, 2025 Q3 2025 |
598,765
shares
|
$26.1 Million
0.26% of portfolio
|
Q3 2025
Reduced 0.88%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
555,410
shares
|
$24.2 Million
0.0% of portfolio
|
Q3 2025
Reduced 0.25%
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Nov 13, 2025 Q3 2025 |
530,098
shares
|
$23.1 Million
0.07% of portfolio
|
Q3 2025
Added 4.92%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
495,491
shares
|
$21.6 Million
0.03% of portfolio
|
Q3 2025
New holding
|
|
|
Boothbay Fund Management, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
495,341
shares
|
$21.6 Million
0.35% of portfolio
|
Q3 2025
Added 10.81%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
491,982
shares
|
$21.5 Million
0.0% of portfolio
|
Q3 2025
Reduced 54.51%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
482,186
shares
|
$21 Million
0.0% of portfolio
|
Q3 2025
Added 1.29%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
416,998
shares
|
$18.2 Million
0.0% of portfolio
|
Q3 2025
Added 42.82%
|
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
Nov 12, 2025 Q3 2025 |
402,943
shares
|
$17.6 Million
0.02% of portfolio
|
Q3 2025
Reduced 1.88%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
395,120
shares
|
$17.2 Million
0.0% of portfolio
|
Q3 2025
Added 1079.85%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2025 Q3 2025 |
367,749
shares
|
$16.1 Million
0.01% of portfolio
|
Q3 2025
Reduced 38.32%
|
|
|
Legal & General Group PLC
London, X0 |
Nov 13, 2025 Q3 2025 |
322,934
shares
|
$14.1 Million
0.0% of portfolio
|
Q3 2025
Added 402.19%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Nov 18, 2025 Q3 2025 |
272,161
shares
|
$11.9 Million
0.01% of portfolio
|
Q3 2025
Reduced 7.66%
|
|
|
Palo Alto Investors LP
Palo Alto, CA |
Nov 14, 2025 Q3 2025 |
265,497
shares
|
$11.6 Million
2.12% of portfolio
|
Q3 2025
Reduced 1.22%
|
|
|
Summit Tx Capital, L.P.
Fort Worth, TX |
Nov 14, 2025 Q3 2025 |
262,977
shares
|
$11.5 Million
0.44% of portfolio
|
Q3 2025
New holding
|
|
|
Eagle Health Investments LP
Greenwich, CT |
Nov 07, 2025 Q3 2025 |
246,230
shares
|
$10.7 Million
2.63% of portfolio
|
Q3 2025
Reduced 25.57%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
242,813
shares
|
$10.6 Million
0.0% of portfolio
|
Q3 2025
Added 104.33%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 13, 2025 Q3 2025 |
226,824
shares
|
$9.9 Million
0.01% of portfolio
|
Q3 2025
Reduced 66.87%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
216,040
shares
|
$9.43 Million
0.0% of portfolio
|
Q3 2025
Added 19.55%
|
|
|
High Vista Strategies LLC
Boston, MA |
Nov 14, 2025 Q3 2025 |
195,298
shares
|
$8.52 Million
2.39% of portfolio
|
Q3 2025
Added 178.49%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
189,866
shares
|
$8.29 Million
0.06% of portfolio
|
Q2 2025
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
183,100
shares
|
$7.99 Million
0.0% of portfolio
|
Q3 2025
Reduced 82.55%
|
|
|
Axa Investment Managers S.A.
Puteaux, I0 |
Nov 14, 2025 Q3 2025 |
177,675
shares
|
$7.76 Million
0.02% of portfolio
|
Q3 2025
New holding
|
|
|
Peregrine Capital Management LLC
|
Oct 23, 2025 Q3 2025 |
162,905
shares
|
$7.11 Million
0.21% of portfolio
|
Q3 2025
New holding
|
|